The market is not really buying the contract; it is buying the probability that management can translate one strategic win into a repeatable revenue curve without giving back margin. In the next 1-2 days, the stock will trade on whether the guide implies backlog conversion, not on the headline dollar value, because the valuation already assumes a lot of execution. If the guide only inches up, the risk is a classic “good news, bad stock” outcome: multiple compression on any sign the revenue is back-end loaded.

Relative winners are the hyperscaler customer and the broader custom-silicon ecosystem, but the second-order winner may be the supplier with the deepest diversification and software pull-through, not necessarily the one with the splashiest deal. That argues for AVGO to retain a premium over MRVL unless Marvell shows multiple repeat wins beyond Google. GOOGL also benefits because custom inference hardware can lower cost per query and reduce dependency on merchant silicon, but the warrant means part of the value transfer is being paid in dilution, so the economics are less clean per share than the contract headline suggests.

Over 1-3 months, the key catalyst is whether management frames 2027/2028 as the start of a multi-customer backlog rather than a one-off design win. Over 6-18 months, the real risk is that hyperscalers slow capex, internalize more of the design stack, or use pricing leverage to keep supplier margins from expanding. The contrarian view is that consensus may be overestimating how much of the AI infra spend accrues to custom-chip vendors versus the platform owners who control deployment timing, software, and purchasing power. What would falsify a bearish stance is clear guidance upside plus evidence of gross-margin expansion; absent that, the stock is priced for perfection.